See also this year's filing and all EDGAR filings for this company.
PDF Report 0001205922_2020_VACCINEX_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001205922, VACCINEX INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 4,010,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 594,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 3,208,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 3,670,000 |
| 7 | CostOfGoodsAndServicesSold | 199,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,669,000 |
| 9 | ResearchAndDevelopmentExpense | 25,670,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 523,000 |
| 12 | remainder_NetIncome | 152,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,604,000 |
| 1 | Liabilities | 6,878,000 |
| 2 | Expenses | 32,538,000 |
| 3 | Revenues | 523,000 |
| 4 | StockholdersEquity | -2,274,000 |
| 5 | NetIncome | -31,863,000 |
| 6 | ComprehensiveNetIncome | -31,863,000 |
| 7 | BaseVar | 22,347,500 |
| 8 | EconomicCapitalRatio | -6.23 |